PA8590701A1 - Nuevo hemisulfato de 1-[4(s)-azido-2 azido (s),3(r)-dihidroxi-4-(hidroximetil)-1(r)-ciclopentil] citosina como agente antiviral util - Google Patents
Nuevo hemisulfato de 1-[4(s)-azido-2 azido (s),3(r)-dihidroxi-4-(hidroximetil)-1(r)-ciclopentil] citosina como agente antiviral utilInfo
- Publication number
- PA8590701A1 PA8590701A1 PA20038590701A PA8590701A PA8590701A1 PA 8590701 A1 PA8590701 A1 PA 8590701A1 PA 20038590701 A PA20038590701 A PA 20038590701A PA 8590701 A PA8590701 A PA 8590701A PA 8590701 A1 PA8590701 A1 PA 8590701A1
- Authority
- PA
- Panama
- Prior art keywords
- azido
- ciclopentil
- dihydroxi
- hydroximethyl
- hemisulfate
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- DUAJIKVIRGATIW-UHFFFAOYSA-N trinitrogen(.) Chemical class [N]=[N+]=[N-] DUAJIKVIRGATIW-UHFFFAOYSA-N 0.000 title 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 abstract 3
- 239000013078 crystal Substances 0.000 abstract 1
- 229940104302 cytosine Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA SAL HEMISULFATO DE 1-[4(S)-AZIDO-2(S), 3(R)-DIHIDROXI-4-(HIDROXIMETIL)-1(R)-CICLOPENTIL]CITOSINA (Ia) CON UNA MAYOR ESTABILIDAD Y MEJORES PROPIEDADES FISICAS, LAS CUALES FACILITAN LA OBTENCION, MANIPULACION Y FORMULACION DE I Y FORMAS CRISTALINAS POLIMORFICAS DEL MISMO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43188502P | 2002-12-09 | 2002-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8590701A1 true PA8590701A1 (es) | 2004-11-26 |
Family
ID=32507815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20038590701A PA8590701A1 (es) | 2002-12-09 | 2003-12-04 | Nuevo hemisulfato de 1-[4(s)-azido-2 azido (s),3(r)-dihidroxi-4-(hidroximetil)-1(r)-ciclopentil] citosina como agente antiviral util |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6864244B2 (es) |
| EP (1) | EP1572711B1 (es) |
| JP (1) | JP4563818B2 (es) |
| KR (1) | KR100675544B1 (es) |
| CN (1) | CN1314697C (es) |
| AR (1) | AR042312A1 (es) |
| AT (1) | ATE430755T1 (es) |
| AU (1) | AU2003292212B2 (es) |
| BR (1) | BR0317146A (es) |
| CA (1) | CA2506532C (es) |
| CY (1) | CY1109296T1 (es) |
| DE (1) | DE60327554D1 (es) |
| DK (1) | DK1572711T3 (es) |
| ES (1) | ES2324654T3 (es) |
| GT (1) | GT200300276A (es) |
| HR (1) | HRP20050503A2 (es) |
| IL (1) | IL168685A (es) |
| JO (1) | JO2542B1 (es) |
| MX (1) | MXPA05006044A (es) |
| MY (1) | MY130927A (es) |
| NO (1) | NO330454B1 (es) |
| NZ (1) | NZ540297A (es) |
| PA (1) | PA8590701A1 (es) |
| PE (1) | PE20040767A1 (es) |
| PL (1) | PL213734B1 (es) |
| PT (1) | PT1572711E (es) |
| RU (1) | RU2334756C2 (es) |
| SI (1) | SI1572711T1 (es) |
| TW (1) | TWI294882B (es) |
| UY (1) | UY28109A1 (es) |
| WO (1) | WO2004052906A1 (es) |
| ZA (1) | ZA200504472B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4577751B2 (ja) * | 1999-09-02 | 2010-11-10 | 塩野義製薬株式会社 | 芳香族ヘテロ環誘導体を含有するインテグラーゼ阻害剤 |
| CA2284459C (en) * | 1999-10-04 | 2012-12-11 | Neokimia Inc. | Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| US20050182252A1 (en) * | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| EP1794172B1 (en) * | 2004-08-23 | 2009-07-15 | F.Hoffmann-La Roche Ag | Antiviral 4'-azido-nucleosides |
| WO2008043704A1 (en) * | 2006-10-10 | 2008-04-17 | Medivir Ab | Hcv nucleoside inhibitor |
| US8071568B2 (en) | 2007-01-05 | 2011-12-06 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
| GB0709791D0 (en) * | 2007-05-22 | 2007-06-27 | Angeletti P Ist Richerche Bio | Antiviral agents |
| GB0900914D0 (en) | 2009-01-20 | 2009-03-04 | Angeletti P Ist Richerche Bio | Antiviral agents |
| CA2812962C (en) | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| WO2015123352A1 (en) | 2014-02-13 | 2015-08-20 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| CN103965116B (zh) * | 2014-05-06 | 2016-06-15 | 中国科学院苏州纳米技术与纳米仿生研究所 | 半5-氟胞嘧啶盐、其制备方法及应用 |
| CN106687118A (zh) | 2014-07-02 | 2017-05-17 | 配体药物公司 | 前药化合物及其用途 |
| CA3182565A1 (en) | 2015-03-06 | 2016-09-15 | Atea Pharmaceuticals, Inc. | .beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment |
| EP3865136A1 (en) | 2016-09-07 | 2021-08-18 | ATEA Pharmaceuticals, Inc. | 2'-substituted-n6-substituted purine nucleotides for corona virus treatment |
| FI3577124T3 (fi) | 2017-02-01 | 2025-02-13 | Atea Pharmaceuticals Inc | Nukleotidihemisulfaattisuola hepatiitti C -viruksen hoitoon |
| WO2019139919A1 (en) | 2018-01-09 | 2019-07-18 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
| KR20200140865A (ko) | 2018-04-10 | 2020-12-16 | 아테아 파마슈티컬즈, 인크. | 간경변증을 갖는 hcv 감염 환자의 치료 |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| MX2023014898A (es) | 2021-06-17 | 2024-04-29 | Atea Pharmaceuticals Inc | Terapia combinada anti-vhc ventajosa. |
| CN115536710B (zh) * | 2022-10-18 | 2024-04-16 | 南京工业大学 | 一种高品质胞苷硫酸盐晶体的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5449664A (en) * | 1988-11-21 | 1995-09-12 | Syntex (U.S.A.) Inc. | Antiviral agents |
| KR900007863A (ko) * | 1988-11-21 | 1990-06-02 | 원본미기재 | 향비루스제 |
| AU7623991A (en) * | 1990-05-17 | 1991-11-21 | Syntex (U.S.A.) Inc. | Antiviral agents |
| ES2195970T3 (es) * | 1996-10-16 | 2003-12-16 | Ribapharm Inc | L-ribavirina y usos de la misma. |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| SI1355916T1 (sl) * | 2001-01-22 | 2007-04-30 | Merck & Co Inc | Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze |
| GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
-
2003
- 2003-12-03 TW TW092134038A patent/TWI294882B/zh not_active IP Right Cessation
- 2003-12-04 PA PA20038590701A patent/PA8590701A1/es unknown
- 2003-12-05 AR ARP030104491A patent/AR042312A1/es unknown
- 2003-12-05 PE PE2003001233A patent/PE20040767A1/es not_active Application Discontinuation
- 2003-12-05 MY MYPI20034678A patent/MY130927A/en unknown
- 2003-12-08 PT PT03767770T patent/PT1572711E/pt unknown
- 2003-12-08 SI SI200331601T patent/SI1572711T1/sl unknown
- 2003-12-08 CA CA2506532A patent/CA2506532C/en not_active Expired - Fee Related
- 2003-12-08 HR HR20050503A patent/HRP20050503A2/xx not_active Application Discontinuation
- 2003-12-08 AU AU2003292212A patent/AU2003292212B2/en not_active Ceased
- 2003-12-08 ES ES03767770T patent/ES2324654T3/es not_active Expired - Lifetime
- 2003-12-08 WO PCT/EP2003/013899 patent/WO2004052906A1/en not_active Ceased
- 2003-12-08 JP JP2004558026A patent/JP4563818B2/ja not_active Expired - Fee Related
- 2003-12-08 EP EP03767770A patent/EP1572711B1/en not_active Expired - Lifetime
- 2003-12-08 DE DE60327554T patent/DE60327554D1/de not_active Expired - Lifetime
- 2003-12-08 KR KR1020057010443A patent/KR100675544B1/ko not_active Expired - Fee Related
- 2003-12-08 MX MXPA05006044A patent/MXPA05006044A/es active IP Right Grant
- 2003-12-08 GT GT200300276A patent/GT200300276A/es unknown
- 2003-12-08 RU RU2005121927/04A patent/RU2334756C2/ru not_active IP Right Cessation
- 2003-12-08 DK DK03767770T patent/DK1572711T3/da active
- 2003-12-08 AT AT03767770T patent/ATE430755T1/de active
- 2003-12-08 NZ NZ540297A patent/NZ540297A/en not_active IP Right Cessation
- 2003-12-08 UY UY28109A patent/UY28109A1/es not_active Application Discontinuation
- 2003-12-08 BR BR0317146-9A patent/BR0317146A/pt not_active IP Right Cessation
- 2003-12-08 PL PL377472A patent/PL213734B1/pl not_active IP Right Cessation
- 2003-12-08 CN CNB2003801053665A patent/CN1314697C/zh not_active Expired - Fee Related
- 2003-12-09 JO JO2003163A patent/JO2542B1/en active
- 2003-12-09 US US10/731,582 patent/US6864244B2/en not_active Expired - Fee Related
-
2005
- 2005-05-19 IL IL168685A patent/IL168685A/en not_active IP Right Cessation
- 2005-05-31 ZA ZA200504472A patent/ZA200504472B/en unknown
- 2005-06-07 NO NO20052732A patent/NO330454B1/no not_active IP Right Cessation
-
2009
- 2009-07-24 CY CY20091100797T patent/CY1109296T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8590701A1 (es) | Nuevo hemisulfato de 1-[4(s)-azido-2 azido (s),3(r)-dihidroxi-4-(hidroximetil)-1(r)-ciclopentil] citosina como agente antiviral util | |
| PE20051132A1 (es) | Composiciones de hidrogel antiinfecciosas | |
| PA8548401A1 (es) | Agentes antibacterianos | |
| AR034619A1 (es) | Formulaciones de olopatadine para administracion topica | |
| DE60320222D1 (de) | Lanzetten betreffende verbesserungen | |
| PE20010130A1 (es) | Derivados de 3(5)-amino-pirazol y procedimiento para su preparacion | |
| AR054461A1 (es) | Composiciones de tabaco | |
| BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
| EP1981548A4 (en) | REINFORCED PRODUCTION OF INFECTIOUS PARVOVIRUS VECTORS IN INSECT CELLS | |
| ECSP088549A (es) | Nuevos derivados de pirrol fusionado | |
| SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
| EA200802203A1 (ru) | Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов | |
| CY1110419T1 (el) | Τρικυκλικες ενωσεις με βαση το 1,6-διυδρο-1,3,5,6-tetpaaza-as-ινδακενιο και φαρμακευτικες συνθεσεις που τις περιεχουν ως αναστολεις της ενζυμικης ενεργοτητας της ικκ | |
| BRPI0412851A (pt) | benzamidazóis de n-metila-substituìdos | |
| GT200300263A (es) | Derivados de indazol como antagonistas del crf | |
| NO20055130D0 (no) | Aminocykloheksyleter-forbindelser og deres anvendelse | |
| ES2192494A1 (es) | Derivados de 1,2,4-triazol con propiedades cannabinoides. | |
| DOP2005000248A (es) | Agentes citotoxicos que comprendentaxanos nuevos. | |
| CU20200100A7 (es) | Compuestos 3-ciano n-sustituidos de hidrotienopiridina útiles para prevenir y tratar las infecciones virales, especialmente dengue, y composiciones farmacéuticas que los contienen | |
| CY1108232T1 (el) | Πυριδιν-4-υλ-αιθυνυλο-ιμιδαζολια και πυραζολια ως ανταγωνιστες υποδοχεα | |
| FR2854160B1 (fr) | Nouveaux derives heterocycliques de l'acide 2-oxothiazolidine4-carboxylique, utilisation comme agent de photoprotection active | |
| UY29802A1 (es) | Análogos de la feniletilamina y su uso en el tratamiento del glaucoma | |
| GT200600262A (es) | Uso de la sangliferina en el hcv (virus de la hepatitis "c") | |
| GT200400025A (es) | Formula agroquimica | |
| GT200300147A (es) | Nuevos derivados de piperidina |